Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.

about

Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.

Item

http://www.wikidata.org/entity/Q38909618

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.

@en

type

Item

label

Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.

@en

prefLabel

Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.

@en

P1476

Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke.

@en

P2093

Afshin A Divani

http://www.w3.org/2001/XMLSchema#string

David S Liebeskind

http://www.w3.org/2001/XMLSchema#string

Eric Bershad

http://www.w3.org/2001/XMLSchema#string

Gundu H R Rao

http://www.w3.org/2001/XMLSchema#string

Magdy Selim

http://www.w3.org/2001/XMLSchema#string

Naila Alakbarova

http://www.w3.org/2001/XMLSchema#string

Nikhil Kapil

http://www.w3.org/2001/XMLSchema#string

Ornina Bachour

http://www.w3.org/2001/XMLSchema#string

Yvonne H Datta

http://www.w3.org/2001/XMLSchema#string

P2860

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke

Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab

Clopidogrel and proton pump inhibitors--where do we stand in 2012?

Cardiology patient page. Warfarin versus novel oral anticoagulants: how to choose?

P304

301-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029616660762

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27461564

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation